FERMT2 and cancer: Knockdown of Kindlin-2 has been reported to lead to a significant reduction in the invasive properties of cancer cells through nuclear factor kappa B (NF-κB)-dependent upregulation of the expression of matrix metallopeptidase (MMP)-9 and MMP-2 [28].